Title : Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation - Hofmann_2021_Chemistry_27_6015 |
Author(s) : Hofmann J , Ginex T , Espargaro A , Scheiner M , Gunesch S , Arago M , Stigloher C , Sabate R , Luque FJ , Decker M |
Ref : Chemistry , 27 :6015 , 2021 |
Abstract : |
PubMedSearch : Hofmann_2021_Chemistry_27_6015 |
PubMedID: 33666306 |
Title : 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo - Gunesch_2020_Redox.Biol_29_101378 |
Author(s) : Gunesch S , Hoffmann M , Kiermeier C , Fischer W , Pinto AFM , Maurice T , Maher P , Decker M |
Ref : Redox Biol , 29 :101378 , 2020 |
Abstract : |
PubMedSearch : Gunesch_2020_Redox.Biol_29_101378 |
PubMedID: 31926632 |
Title : Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model - Hoffmann_2019_J.Med.Chem_62_9116 |
Author(s) : Hoffmann M , Stiller C , Endres E , Scheiner M , Gunesch S , Sotriffer C , Maurice T , Decker M |
Ref : Journal of Medicinal Chemistry , 62 :9116 , 2019 |
Abstract : |
PubMedSearch : Hoffmann_2019_J.Med.Chem_62_9116 |
PubMedID: 31609115 |
Title : Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo - Scheiner_2019_J.Med.Chem_62_9078 |
Author(s) : Scheiner M , Dolles D , Gunesch S , Hoffmann M , Nabissi M , Marinelli O , Naldi M , Bartolini M , Petralla S , Poeta E , Monti B , Falkeis C , Vieth M , Hubner H , Gmeiner P , Maitra R , Maurice T , Decker M |
Ref : Journal of Medicinal Chemistry , 62 :9078 , 2019 |
Abstract : |
PubMedSearch : Scheiner_2019_J.Med.Chem_62_9078 |
PubMedID: 31609608 |
Title : Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles - Dolles_2018_J.Med.Chem_61_1646 |
Author(s) : Dolles D , Hoffmann M , Gunesch S , Marinelli O , Moller J , Santoni G , Chatonnet A , Lohse MJ , Wittmann HJ , Strasser A , Nabissi M , Maurice T , Decker M |
Ref : Journal of Medicinal Chemistry , 61 :1646 , 2018 |
Abstract : |
PubMedSearch : Dolles_2018_J.Med.Chem_61_1646 |
PubMedID: 29400965 |